Summary
Benzodiazepines are frequently prescribed for elderly patients living in the community and for those in hospitals and institutions. Their use is more prevalent in women. Prolonged use of benzodiazepines is particularly likely in old age for the treatment not only of insomnia and anxiety, but also of a wide range of nonspecific symptoms. Long term users are likely to have multiple concomitant physical and psychological health problems.
The distinction between benzodiazepine anxiolytics and hypnotics is difficult and somewhat arbitrary, since the differences between the compounds are less than their similarities, especially in respect of adverse reactions. Despite their wide therapeutic range, elderly patients are particularly prone to adverse reactions to benzodiazepines. The incidence of unwanted effects, predominantly manifestations of central nervous system depression, has been found to be significantly increased in hospitalised elderly patients, particularly in the frail elderly. Studies on unwanted effects during long term use are scarce, but there is some evidence of tolerance to side effects. However, benzodiazepines have been found to be frequently implicated in drug-associated hospital admissions. There is suggestive evidence that benzodiazepines, especially compounds with long half-lives, may contribute to the falls which are a major health problem in old age.
The incidence of benzodiazepine dependence in elderly patients is unknown. The features of benzodiazepine withdrawal in the elderly may differ from those seen in young patients; withdrawal symptoms include confusion and disorientation which often does not precipitate milder reactions such as anxiety, insomnia and perceptual changes. Problems due to both adverse reactions and to benzodiazepine withdrawal may easily be overlooked in multimorbid elderly patients, particularly in those suffering from disorders of the central nervous system.
There are numerous studies on benzodiazepine pharmacokinetics indicating that alterations, especially in distribution and elimination of certain compounds, occur in old age. Benzodiazepines with oxidative metabolic pathways and longer half-lives are likely to accumulate with regular administration. However, changes in pharmacodynamics may be more important to explain altered responses to benzodiazepines in the elderly. Although information on pharmacodynamics is still limited, there is convincing evidence of increased pharmacodynamic response in the elderly which may be further accentuated by disease factors. Since the variability of pharmacological response increases with age and is not always predictable, there is good reason at least to start therapy at lower doses and to titrate dosages individually. This may also be appropriate for the newer benzodiazepines, irrespective of advantageous pharmacokinetics.
Problems in the use of benzodiazepines will arise if the available knowledge on altered pharmacokinetics and pharmacodynamics and principal guidelines for drug prescribing in the elderly are neglected. Poor prescribing habits are related mainly to inadequate clinical assessment, excessive prescribing and inadequate supervision of treatment. Unlimited repeat prescribing, particularly for the treatment of sleep disturbances, is seldom justified. Fortunately, many elderly patients use prescribed drugs much more judiciously than is commonly assumed.
Similar content being viewed by others
References
Abernethy DR. Methodological concerns for clinical trials in geriatrics: benzodiazepines. In Cutler & Narang (Eds) Drug studies in the elderly: methodological concerns, pp. 189–205, Plenum Medical Book Company, New York and London, 1986
Alexander N, Goodwin JS, Currie C. Comparison of admission and discharge medications in two geriatric populations. Journal of the American Geriatrics Society 33: 827–832, 1985
Ancill RJ, Embury GD, MacEwan GW, Kennedy JS. Lorazepam in the elderly — a retrospective study of the side effects in 20 patients. Journal of Psychopharmacology 2: 126–127, 1987
Aoki FY, Hildahl VK, Urge GW, Mitenko PA, Sitar DS. Aging and heavy drug use: a prescription survey in Manitoba. Journal of Chronic Diseases 36: 67–73, 1983
Ashton H. Risks of dependence on benzodiazepine drugs: a major problem of long term treatment. British Medical Journal 298: 103–104, 1989
Austin R, Parish P. Prescriptions written by ancillary staff. Journal of the Royal College of General Practitioners 26 (Suppl. 1): 44–49, 1976
Avorn J, Dreyer P, Connelly K, Soumerai SB. Use of psychoactive medication and the quality of care in rest homes. New England Journal of Medicine 320: 227–237, 1989
Baker MI, Oleen MA. The use of benzodiazepine hypnotics in the elderly. Pharmacotherapy 8: 241–247, 1988
Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In Goodman & Gilman (Eds) The pharmacological basis of therapeutics, 7th ed., pp. 387–445, Macmillan Publishing Company, New York, 1985
Balter MB, Mannheimer DI, Mellinger GD, Uhlenhuth EH. A cross-national comparison of anti-anxiety/sedative drug use. Current Medical Research and Opinion 8 (Suppl. 4): 5–20, 1984
Bayer AJ, Pathy MS. Requests for hypnotic drugs and placebo response in elderly hospital inpatients. Postgraduate Medical Journal 61: 317–320, 1985
Beardsley RS, Larson DB, Burns BJ, Thompson JW, Kamerow DB. Prescribing of psychotropics in elderly nursing home patients. Journal of the American Geriatrics Society 37: 327–330, 1989
Beers MH, Dang J, Hasegawa J, Tamai IY. Influence of hospitalization on drug therapy in the elderly. Journal of the American Geriatrics Society 37: 679–683, 1989a
Beers MH, Ouslander JG. Risk factors in geriatric drug prescribing: a practical guide to avoiding problems. Drugs 37: 105–112, 1989b
Bell GD, Spickett GP, Reeve PA, Morden A, Logan RFA. Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient. British Journal of Clinical Pharmacology 23: 241–243, 1987
Bergman U, Christenson I, Jansson B, Wiholm B-E. Auditing hospital drug utilisation by means of defined daily doses per bed-day: a methodological study. European Journal of Clinical Pharmacology 17: 183–187, 1980
Beveridge T, Petrie JC. Transfer of information about intake of drugs by patients referred to medical units. British Medical Journal 2: 37–39, 1972
Bianchine JR. Drugs for Parkinson’s disease, spasticity, and acute muscle spasms. In Goodman & Gilman (Eds) The pharmacological basis of therapeutics, 7th ed., pp. 473–490, Macmillan Publishing Company, New York, 1985
Bixler EO, Kales A, Brubaker BH, Kales JD. Adverse reactions to benzodiazepine hypnotics: spontaneous reporting system. Pharmacology 35: 286–300, 1987
Blake AJ, Morgan K, Bendall MJ, Dalosso H, Ebrahim SBJ, et al. Falls by elderly people at home: prevalence and associated factors. Age and Ageing 17: 365–372, 1988
Boethius G. Recording of drug prescriptions in the country of Jämtland, Sweden: pattern of drug usage in 16 600 individuals during 1970–75. Acta Medica Scandinavica 202: 241–251, 1977
Borbély A. Schlafgewohnheiten, Schlafqualität und Schlafmittelkonsum der Schweizer Bevölkerung: Ergebnisse einer Repräsentativumfrage. Schweizer Ärztezeitung 65: 1606–1613, 1984
Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age. New England Journal of Medicine 288: 277–280, 1973
Briggs RS, Castleden CH, Kraft CA. Improved hypnotic treatment using chlormethiazole and temazepam. British Medical Journal 280: 601–604, 1980
Brocklehurst JC, Robertson D, James-Groom P. Clinical correlates of sway in old age — sensory modalities. Age and Ageing 11: 1–10, 1982
Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. Journal of the American Medical Association 257: 1492–1495, 1987
Buck JA. Psychotropic drug practice in nursing homes. Journal of the American Geriatrics Society 36: 409–418, 1988
Busto U, Sellers EH, Naranjo CA, Cappell H, Sanchez-Craig M, et al. Withdrawal reaction after long-term therapeutic use of benzodiazepines. New England Journal of Medicine 315: 854–859, 1986
Caird FI, Scott, PJW. Drug-induced diseases in the elderly: a critical survey of the literature. In Dukes (Ed.) Drug-induced disorders, Vol. 2, pp. 186–188, Elsevier, Amsterdam, 1986
Campbell AJ, Reinken J, Allan BC, Martinez GS. Falls in old age: a study of frequency and related clinical factors. Age and Ageing 10: 264–270, 1981
Campbell AJ, Somerton DT. Benzodiazepine drug effect on body sway in elderly subjects. Journal of Clinical and Experimental Gerontology 4: 341–347, 1982
Campion EW, Avorn J, Reder VA, Olins NJ. Overmedication of the low-weight elderly. Archives of Internal Medicine 147: 945–947, 1987
Carskadon MA, Seidel WF, Greenblatt DJ, Dement WC. Daytime carryover of tiazolam and flurazepam in elderly insomniacs. Sleep 5: 361–371, 1982
Cartwhright A, Smith C. Elderly people, their medicines and their doctors. Routledge, London, 1988
Castleden CH, George CF, Marcer D, Hallen C. Increased sensitivity to nitrazepam in old age. British Medical Journal 1: 10–12, 1977
Castleden CM. Studies on the prevalence of adverse drug reactions in the elderly, MD Thesis, London University, London, 1979
Castleden CM, Allen JG, Altmann J, John-Smith PS. A comparison of oral midazolam, nitrazepam and placebo in young and elderly subjects. European Journal of Clinical Pharmacology 32: 253–257, 1987
Castleden CM, Swift CG. Hypnotics, sedatives, and anticonvulsants. In Swift (Ed.) Clinical pharmacology in the elderly, pp. 281–341, Marcel Dekker, Inc., New York, 1987
Catalan J, Gath DH. Benzodiazepines in general practice: time for a decision. British Medical Journal 290: 1374–1376, 1985
Catalan J, Gath D, Edmonds G, Ennis J. The effects of non-prescribing of anxiolytics in general practice: I. Controlled evaluation of psychiatric and social outcome. British Journal of Psychiatry 144: 593–602, 1984a
Catalan J, Gath D, Bond A, Martin P. The effect of non-prescribing of anxiolytics in general practice: II. Factors associated with outcome. British Journal of Psychiatry 144: 603–610, 1984b
Christopher LJ, Ballinger BR, Shepherd AMM, Ramsay A, Crooks G. Drug prescribing patterns in the elderly: a cross-sectional study of in-patients. Age and Ageing 7: 74–82, 1978
Cook PJ. Benzodiazepine hypnotic in the elderly. Acta Psychiatrica Scandinavica 74 (Suppl. 332): 149–158, 1986
Cook PJ, Flanagan R, James IM. Diazepam tolerance: effect of age, regular sedation, and alcohol. British Medical Journal 284: 351–353, 1984
Cook PJ, Huggett A, Graham-Pole R, Savage IT, James IM. Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. British Medical Journal 286: 100–102, 1983
Crapo LM, Melmon KL. Optimal therapy for the geriatric patient: the challenge to clinical pharmacology. Journal of Chronic Diseases 36: 39–52, 1983
Crooks J. Rational therapeutics in the elderly. Journal of Chronic Diseases 36: 59–65, 1983a
Crooks J. Aging and drug disposition — pharmacodynamics. Journal of Chronic Diseases 36: 85–90, 1983b
Davie J, Blumenthal M, Robinson-Hawkins S. A model of risk of falling for psychogeriatric patients. Archives of General Psychiatry 38: 463–467, 1981
Di Bella GAW. Update on hypnotics for insomnia in clinical practice: I. Hypnotics. Mount Sinai Journal of Medicine 53: 82–89, 1986
Droller H. Falls among elderly people living at home. Geriatrics 10: 239–244, 1955
Dunne FJ, Schipperheijn JAM. Alcohol and the elderly: need for greater awareness. British Medical Journal 298: 1660–1661, 1989
Evans JG. Falls and fractures. Age and Ageing 17: 361–364, 1988
Evans JG, Jarvis EH. Nitrazepam and the elderly. British Medical Journal 4: 487, 1972
Evans JG, Prudham D, Wandless I. A prospective study of fractured proximal femur: factors and predisposing to survival. Age and Ageing 8: 246–250, 1979
Feist R. A survey of accidental falls in a small home for the aged. Journal of Gerontological Nursing 4: 15–17, 1978
Foy A, Drinkwater V, March S, Mearrick P. Confusion after admission to hospital in elderly patients using benzodiazepines. British Medical Journal 293: 1072, 1986
Freeman GK. Drug prescribing patterns in the elderly — a general practice study. In Crooks & Stevenson (Eds) Drugs and the elderly: perspectives in geriatric clinical pharmacology, pp. 223–229, Macmillan Press, London, 1979
Gagnon M-A, Langlois Y, Boghen DR, Verdy M. Effects of halazepam and dizepam on the motor coordination of geriatric subjects. European Journal of Clinical Pharmacology 11: 443–448, 1977
Gerson SC, Plotkin DA, Jarvik LF. Antidepressant drug studies, 1964 to 1986: empirical evidence for aging patients. Journal of Clinical Psychopharmacology 8: 311–322, 1988
Gilchrist WJ, Lee YC, Tarn HC, Macdonald JB, Williams BO. Prospective study of drug reporting by general practitioners for an elderly population referred to a geriatric service. British Medical Journal 294: 289–290, 1987
Giles HG, MacLeod SM, Wright JR, Sellers EM. Influence of age and previous use on diazepam dosage required for endoscopy. Canadian Medical Association Journal 118: 513–514, 1978
Goldberg D, Blackwell B. Psychiatric illness in general practice: a detailed study using a new method of case identification. British Medical Journal 2: 439–443, 1970
Goldberg D, Kay C, Thompson L. Psychiatric morbidity in general practice and the community. Psychological Medicine 6: 565–569, 1976
Goldson RL. Management of sleep disorders in the elderly. Drugs 21: 390–396, 1981
Granek E, Baker SP, Abbey H, Robinson E, Myers AH, et al. Medications and diagnoses in relation to falls in a long-term care facility. Journal of the American Geriatrics Society 35: 503–511, 1987
Greenblatt DJ, Koch-Weser J. Clinical toxicity of chlordiazepoxide and diazepam in relation to serum albumin concentration: a report from the Boston Collaborative Drug Surveillance Program. European Journal of Clinical Pharmacology 7: 259–262, 1974
Greenblatt DJ, Allen MD. Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. British Journal of Clinical Pharmacology 5: 407–413, 1978
Greenblatt DJ, Allen MD, Noel BJ, Shader RI. Acute overdosage with benzodiazepine derivates. Clinical Pharmacology and Therapeutics 21: 497–514, 1977a
Greenblatt DJ, Allen MD, Shader RI. Toxicity of high-dose flurazepam in the elderly. Clinical Pharmacology and Therapeutics 21: 355–361, 1977b
Greenblatt DJ, Divoll M, Harmatz JS, Maclaughlin DS, Shader RI. Kinetics and clinical effects of flurazepam in young and elderly insomniacs. Clinical Pharmacology and Therapeutics 30: 475–486, 1981
Greenblatt DJ, Sellers EM, Shader RI. Drug disposition in old age. New England Journal of Medicine 306: 1081–1088, 1982
Greenblatt DJ, Shader RI, Abernethy DR. Current status of benzodiazepines. New England Journal of Medicine 309: 354–358, 410-416, 1983
Greenblatt DJ, Shader RI, Divoll M, Harmatz JS. Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials. Journal of Clinical Psychiatry 45: 192–195, 1984
Greenblatt DJ, Harmatz JS, Zinny MA, Shader RI. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. New England Journal of Medicine 317: 722–728, 1987
Greenblatt DJ, Shader RI, Abernethy DR. The psychopharmacokinetics of old age. In Barches & Bunney (Eds) Perspectives in psychopharmacology: a collection of papers in honor of Earl Usdin, pp. 605–612, Alan R. Liss, Inc., New York, 1988
de Groot MHL. The clinical use of psychotherapeutic drugs in the elderly. Drugs 8: 132–138, 1974
Gryfe CI, Amies A, Ashley MJ. A longitudinal study of falls in an elderly population: I. Incidence and morbidity. Age and Ageing 6: 201–210, 1977
Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery PR. Drug-associated hospital admissions in older medical patients. Journal of the American Geriatrics Society 36: 1092–1098, 1988
Gullick EL, King LJ. Appropriateness of drugs prescribed by primary care physicians for depressed outpatients. Journal of Affective Disorders 1: 55–58, 1979
Hale WE, Stewart RB, Marks RG. Antianxiety drugs and central nervous system symptoms in an ambulatory elderly population. Drug Intelligence and Clinical Pharmacy 19: 37–40, 1985
Hall RCW, Popkin MK, Gardner ER. Clinical pharmacology and use of benzodiazepines in the elderly. In Levenson (Ed.) Geriatric psychopharmacotherapy: optimal technique, pp. 59–85, Charles C. Thomas, Springfield, 1982
Harvey SC. Hypnotics and sedatives. In Goodman & Gilman (Eds) The pharmacological basis of therapeutics, 7th ed., pp. 339–371, Macmillan Publishing Company, New York, 1985
Helms PM. Efficacy of antipsychotics in the treatment of the behavioral complications of dementia: a review of the literature. Journal of the American Geriatrics Society 33: 206–209, 1985
Higgitt A, Lader MH, Fonagy P. Clinical management of benzodiazepine dependence. British Medical Journal 291: 688–690, 1985
Hollister LE. Valium: a discussion of current issues. Psychosomatics 18: 44–58, 1977
Hollister LE. Psychiatric disorders. In Speight (Ed.) Avery’s drug treatment: principles and practice of clinical pharmacology and therapeutics, pp. 1137–1206, ADIS Press, Auckland, 1987
Ingman S, Lawson I, Pierpadi P, Blake P. A survey of prescribing patterns in a long-term institution for the elderly. Journal of the American Geriatrics Society 23: 309–316, 1975
James DS. Survey of hypnotic drug use in nursing homes. Journal of the American Geriatrics Society 33: 436–439, 1985
Jerram TC. Hypnotics and sedatives. In Dukes & Beely (Eds) Side effects of drugs annual 12: a worldwide yearly survey of new data and trends, pp. 40–49, Elsevier, Amsterdam, 1988
Kalchthaler T, Bascom RA, Quintos V. Falls in the institutionalized elderly. Journal of the American Geriatrics Society 26: 424–428, 1978
Kalchthaler T, Coccaro E, Lichtiger S. Incidence of polypharmacy in a long-term care facility. Journal of the American Geriatrics Society 25: 308–313, 1977
Kanto J, Kangas L, Aaltonen L, Hilke H. Effect of age on the pharmacokinetics and sedative effect of flunitrazepam. International Journal of Clinical Pharmacology, Therapy and Toxicology 19: 400–404, 1981
Kesson CM, Gray MB, Lawson DH. Benzodiazepine drugs in general medical patients. British Medical Journal 1: 680–682, 1976
Klein LE, German PS, Levine DM, Feroli ER, Ardery J. Medication problems among outpatients: a study with emphasis on the elderly. Annals of Internal Medicine 144: 1185–1188, 1984
Kruse W, Eggert-Kruse W, Müller S, Kreissler-Haag D, Schlierf G. Vergleich der Aufnahme- und Entlassungsmedikation bei 207 Patienten einer geriatrischen Klinik. Klinische Wochenschrift 68 (Suppl. XIX): 50–51, 1990
Lachnit KS, Proszowski E, Rieder L. Midazolam in the treatment of sleep disorders in geriatric patients. British Journal of Clinical Pharmacology 16: 173S–177S, 1983
Lader MH. Drug development optimization — benzodiazepines. In Weber et al. (Eds) Risk for adverse drug reactions — epidemiological approaches, pp. 59–69, Birkhäuser Verlag, Basel, 1990
Lader MH, Petursson H. Rational use of anxiolytic/sedative drugs. Drugs 25: 514–528, 1983
Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Annals of Internal Medicine 107: 169–173, 1987
Law D, Chalmers C. Medicines and elderly people: a general practice survey. British Medical Journal 1: 565–568, 1976
Lindesay J. Trends in self-poisoning in the elderly 1974-1983. International Journal of Geriatric Psychiatry 1: 37–43, 1986
Litsch M, Reichelt H. Arzneiverordnungen nach Arztgruppen. In Schwabe & Paffrath (Eds) Arzneiverordnungsreport ’89, pp. 426–432, Gustav Fischer Verlag, Stuttgart, 1989
Loew F, Pawlak C, Benaroyo L, Junod J-P. Comparison of midazolam and oxazepam as hypnotics in elderly hospitalized patients. Drug Research 38: 563–567, 1988
Lohse MJ, Müller-Oerlinghausen B. Psychopharmaka. In Schwabe & Paffrath (Eds) Arzneiverordnungsreport ’89, pp. 352–367, Gustav Fischer Verlag, Stuttgart, 1989
Macdonald JB, Macdonald ET. Nocturnal femoral fracture and continuing widespread use of barbiturate hypnotics. British Medical Journal 2: 483–485, 1977
Macdonald JB. The role of drugs in falls in the elderly. In Radebaugh et al. (Eds) Falls in the elderly: biologic and behavioral aspects, clinics in geriatric medicine, Vol. 1, pp. 621–636, W.B. Saunders Company, Philadelphia, 1985
Maki BE, Holliday PJ, Fernie GR. Aging and postural control. A comparison of spontaneous — and induced — sway balance tests. Journal of the American Geriatrics Society 38: 1–9, 1990
Manasse AP. Repeat prescriptions in general practice. Journal of the Royal College of General Practitioners 24: 203–207, 1974
Mann AH, Graham N, Ashby D. The prescription of psychotropic medication in local authority old people’s homes. International Journal of Geriatric Psychiatry 1: 25–29, 1986
Marks J. An international overview. In Smith & Wesson (Eds) The benzodiazepines: current standards for medical practice, pp. 67–86, MTP Press Ltd., Lancaster, 1985
Marttila JK, Hammel RJ, Alexander B, Zustiak R. Potential untoward effects of long-term use of flurazepam in geriatric patients. Journal of the American Pharmaceutical Association 17: 692–695, 1977
MacGhie A, Russel SM. The subjective assessment of normal sleep patterns. Journal of Mental Science 108: 642–654, 1962
Mellinger GD, Balter MB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. Journal of the American Medical Association 251: 375–379, 1984
Meyer BR. Benzodiazepines in the elderly. Medical Clinics of North America 66: 1017–1035, 1982
Miller RR, Greenblatt DJ. Hypnotics. In Miller & Greenblatt (Eds) Drug effects in hospitalized patients: experiences of the Boston Collaborative Drug Surveillance Program 1966-1975, pp. 171–191, John Wiley and Sons, New York, 1976
Morgan K. Effect of low-dose nitrazepam on performance in the elderly. Lancet 1: 516, 1982
Morgan K. Sedative-hypnotic drug use and ageing. Archives of Gerontology and Geriatrics 2: 181–199, 1983
Morgan K, Dallosso H, Ebrahim S, Arie T, Fentem PH. Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home. British Medical Journal 296: 601–602, 1988a
Morgan K, Dallosso H, Ebrahim S, Arie T, Fentem PH. Characteristics of subjective insomnia in the elderly living at home. Age and Ageing 17: 1–7, 1988b
Morgan K, Gilleard CJ, Reive A. Hypnotic usage in residential homes for the elderly: a prevalence and longitudinal analysis. Age and Ageing 11: 229–234, 1982
Morgan K, Healey DW, Healey PJ. Factors influencing persistent subjective insomnia in old age: a follow-up study of good and poor sleepers aged 65 to 74. Age and Ageing 18: 117–122, 1989
Müller-Oerlinghausen B, Schmidt LG. Prescription of psychotropic drugs in Germany. In Kewitz et al. (Eds) Epidemiological concepts in clinical pharmacology, pp. 125–137, Springer-Verlag, Berlin, 1987
Murphy P, Hindmarch I, Hyland CM. Aspects of short-term use of two benzodiazepine hypnotics in the elderly. Age and Ageing 11: 222–228, 1982
Nayal S, Castleden CM, George CF, Marcer D. The effect of an hypnotic with short half-life on hangover effect in old patients. Age and Ageing 7 (Suppl.): 50–54, 1978
Nicholsen AN. Hypnotics: their place in therapeutics. Drugs 31: 164–176, 1986
Nielson CP, Cusack PJ, Vestal RE. Geriatric clinical pharmacology and therapeutics. In Speight (Ed.) Avery’s drug treatment: principles and practice of clinical pharmacology and therapeutics, 3rd ed., pp. 160–193, ADIS Press, Auckland, 1987
Nolan L, O’Malley K. Prescribing for the elderly: Part II, Prescribing patterns: differences due to age. Journal of the American Geriatrics Society 36: 245–254, 1988
Nolan L, O’Malley K. The need for a more rational approach to drug prescribing for elderly people in nursing homes. Age and Ageing 18: 52–56, 1989
Ochs HR, Miller LG, Greenblatt DJ, Shader RI. Actual versus reported benzodiazepine usage by medical outpatients. European Journal of Clinical Pharmacology 32: 383–388, 1987
O’Dowd JJ, Spragg PP, Routledge PA. Fatal triazolam poisoning. British Medical Journal 297: 1048, 1988
Overstall PW, Exton-Smith AN, Imms FJ, Johnson AL. Falls in the elderly related to postural imbalance. British Medical Journal 1: 261–264, 1977
Overstall PW, Oldmann PN. A comparative study of lormetazepam and chlormethiazole in elderly in-patients. Age and Ageing 16: 45–51, 1987
Owen RT, Tyrer P. Benzodiazepine dependence: a review of the evidence. Drugs 25: 385–398, 1983
Paffrath D. Arzneimittelverordnungen nach Altersgruppen. In Schwabe & Paffrath (Eds) Arzneiverordnungsreport ’89, pp. 416–425, Gustav Fischer Verlag, Stuttgart, 1989
Paganini-Hill A, Ross RK, Gerhans VR, Henderson BE, Arthur M, et al. Menopausal estrogen therapy and hip fractures. Annals of Internal Medicine 95: 28–31, 1981
Parish PA. The prescribing of psychotropic drugs in general practice. Journal of the Royal College of General Practitioners 21 (Suppl. 4): 1–77, 1971
Parrish HM, Weil TP. Patient accidents occurring in hospitals: epidemiologic study of 614 accidents. New York State Journal of Medicine 58: 838–846, 1958
Pinsker H, Suljaga-Petchel K. Use of benzodiazepines in primarycare geriatric patients. Journal of the American Geriatrics Society 32: 595–597, 1984
Pomara N, Stanley B, Block R, Berdon RC, Stanley M, et al. Increased sensitivity of the elderly to the central depressant effects of diazepam. Journal of Clinical Psychiatry 46: 185–187, 1985
Pomara N, Stanley B, Block R, Guido J, Russ D, et al. Adverse effects of single therapeutic doses of diazepam on performance in normal geriatric subjects: relationship to plasma concentrations. Psychopharmacology 84: 342–346, 1984
Primrose WR, Capewell AE, Simpson GK, Smith RG. Prescribing patterns observed in registered nursing homes and long-stay geriatric wards. Age and Ageing 16: 25–28, 1987
Prudham D, Evans JG. Factors associated with falls in the elderly: a community study. Age and Ageing 10: 141–146, 1981
Puder R, Lacks P, Bertelson AD, Storandt M. Short-term stimulus control treatment of insomnia in older adults. Behavior Therapy 14: 424–429, 1983
Rall TW, Schleifer LS. Drugs effective in the therapy of epilepsies. In Goodman & Gilman (Eds) The pharmacological basis of therapeutics, 7th ed., pp. 446–472, Macmillan Publishing Company, New York, 1985
Rashiq S, Logan RFA. Role of drugs in fractures of the femoral neck. British Medical Journal 292: 861–863, 1986
Ray WA, Federspiel CF, Schaffener W. A study of antipsychotic drug use in nursing homes: epidemiological evidence suggesting misuse. American Journal of Public Health 70: 485–491, 1980
Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine 316: 363–369, 1987
Reidenberg MM. Drug therapy in the elderly: the problem from the point of view of a clinical pharmacologist. Clinical Pharmacology and Therapeutics 42: 677–680, 1987
Reidenberg MM, Levy M, Warner H, Coutinko CB, Schwartz MA, et al. Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clinical Pharmacology and Therapeutics 23: 371–374, 1978
Reynolds MD. Institutional prescribing for the elderly: patterns of prescribing in a municipal nursing home. Journal of the American Geriatrics Society 32: 640–645, 1984
Rickels K, Case G, Downing RW, Winokur A. Long-term diazepam therapy and clinical outcome. Journal of the American Medical Association 250: 767–771, 1983
Rickeis K, Case GW, Winokur A, Swenson C. Long-term benzodiazepine therapy: benefits-and risks. Psychopharmacology Bulletin 20: 608–615, 1984
Robbins AS, Rubenstein LZ, Josephson KR, Schulman BL, Osterwiel D, et al. Predictors of falls among elderly people. Results of two population-based studies. Archives of Internal Medicine 149: 1628–1633, 1989
Rodrigo EK, King MB, Williams P. Health of long term benzodiazepine users. British Medical Journal 296: 603–606, 1988
Royal College of Physicians. Medication for the elderly. Journal of the Royal College of Physicians of London 18: 7–17, 1984
Rudorfer MV, Potter WZ. Antidepressants: a comparative review of the clinical pharmacology and therapeutic use of the ‘newer’ versus the ‘older’ drugs. Drugs 37: 713–738, 1989
Salem SAM, Kinney CD, McDevitt DG. Pharmacokinetics and psychomotor effects of nitrazepam and temazepam in healthy elderly males and females. British Journal of Clinical Pharmacology 11: 601P–602P, 1981
Salinsky JV, Dore CJ. Characteristics of long-term benzodiazepine users in general practice. Journal of the Royal College of General Practitioners 37: 202–204, 1987
Salzman C, Shader RI, Greenblatt DJ, Harmatz JS. Long v short half-life benzodiazepines in the elderly. Archives of General Psychiatry 40: 293–297, 1983
Salzman C, Shader RI, Harmatz J, Robertson L. Psychopharmacologic investigations in elderly volunteers: effect of diazepam in males. Journal of the American Geriatrics Society 23: 451–457, 1975
Schweizer E, Case WG, Rickeis K. Benzodiazepine dependence and withdrawal in elderly patients. American Journal of Psychiatry 164: 529–531, 1989
Sharma JC, MacLennan WJ. Causes of ataxia in patients attending a falls laboratory. Age and Ageing 17: 94–102, 1988
Shaw SM, Opit LJ. Need for supervision in the elderly receiving long-term prescribed medication. British Medical Journal 1: 505–507, 1976
Sheldon JH. On the natural history of falls in old age. British Medical Journal 1: 1685–1690, 1960
Shepherd M, Cooper B, Brown AC, Kalten GW. Psychiatric illness in general practice. Oxford University Press, London, 1966
Sjoqvist F, Alván G, Bergman U, Boethius G. Drug dosage in the elderly — theory and practice. In Crooks & Stevenson (Eds) Drugs and the elderly: perspectives in geriatric clinical pharmacology, pp. 279–286, Macmillan Press, London, 1979
Skegg DCG, Doll R, Perry J. Use of medicines in general practice. British Medical Journal 1: 1561–1563, 1977
Skoll SL, Angus RJ, Johnson GE. Drug prescribing for the elderly in Saskatchewan during 1976. Canadian Medical Association Journal 121: 1074–1081, 1979
Smith TC, Wollman H. History and principles of anesthesiology. In Goodman & Gilman (Eds) The pharmacological basis of therapeutics, 7th ed., pp. 260–275, Macmillan Publishing Company, New York, 1985
Sobel K, MacCart G. Drug use and accidental falls in an intermediate care facility. Drug Intelligence and Clinical Pharmacy 17: 539–542, 1983
Solomon F, White CC, Parron DL, Mendelson WB. Sleeping pills, insomnia and medical practice. New England Journal of Medicine 300: 803–808, 1979
Solow C. Psychotropic drugs in somatic disorder. International Journal of Psychiatry in Medicine 6: 267–282, 1975
Sorock G. A case-control study of falling incidents among the hospitalized elderly. Journal cf Safety Research 14: 47–52, 1983
Sorock GS, Shimkin EE. Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort. Archives of Internal Medicine 148: 2441–2444, 1988
Spagnoli A, Ostino G, Borga AD, D’Ambrosio R, Maggiorotti P, et al. Drug compliance and unreported drugs in the elderly. Journal of the American Geriatrics Society 37: 619–624, 1989
Speirs CJ, Navey FL, Brooks DJ, Impallomessi MG. Opisthotonos and benzodiazepine withdrawal in the elderly. Lancet 2: 1101, 1986
Stevenson P, Gaskell PG. The prescribing of hypnotics in an urban practice. Journal of the Royal College of General Practitioners 21: 529–534, 1971
Sullivan CF, Copeland JRM, Dewey ME, Davidson IA, Mc-William C, et al. Benzodiazepine usage amongst the elderly: findings of the Liverpool Community Survey. International Journal of Geriatric Psychiatry 3: 289–292, 1988
Sunter JP, Bal TS, Cowan WK. Three cases of fatal triazolam poisoning. British Medical Journal 297: 719, 1988
Svenson SE, Hamilton RG. A critique of overemphasis on side effects with the psychotropic drugs: an analysis of 18,000 chlordiazepoxide treated cases. Current Therapeutic Research 8: 445–464, 1966
Swift CG. Postural instability as a measure of sedative drug response. British Journal of Clinical Pharmacology 18: 875–905, 1984
Swift CG. Benzodiazepine pharmacodynamics in the elderly. In O’Malley & Waddington (Eds) Therapeutics in the elderly. Scientific foundations and clinical practice, pp. 77–90, Excerpta Medica, Amsterdam, 1985
Swift CG, Ewen JM, Clarke P, Stevenson IH. Responsiveness to oral diazepam in the elderly: relationship to total and free plasma concentrations. British Journal of Clinical Pharmacology 20: 111–118, 1985a
Swift CG, Haythorne JM, Clarke P, Stevenson IH. The effect of ageing on measured responses to single doses of oral temazepam. British Journal of Clinical Pharmacology 11: 413P-414P, 1981
Swift CG, Swift MR, Ankier SI, Pidgen A, Robinson J. Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly. British Journal of Clinical Pharmacology 20: 119–128, 1985b
Swift CG, Swift MR, Hamley J, Stevenson IH, Crooks J. CNS effects of chronic benzodiazepine hypnotic ingestion in the elderly. British Journal of Clinical Pharmacology 16: 217B–218P, 1983
Swift CG, Swift MR, Hamley J, Stevenson IH, Crooks J. Side-effects ‘tolerance’ in elderly long-term recipients of benzodiazepine hypnotics. Age and Ageing 13: 335–343, 1984
Taggart HMcA. Do drugs affect the risk of hip fracture in elderly women? Journal of the American Geriatrics Society 36: 1006–1010, 1988
Taylor D. Current use of benzodiazepines in Britain. In The benzodiazepines in current annual practice, pp. 13–18, 1987, Royal Society of Medicine Services, 1987
Tinetti ME, Speechley M. Prevention of falls among the elderly. New England Journal of Medicine 320: 1055–1059, 1989
Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. New England Journal of Medicine 319: 1701–1707, 1988
Tinetti ME, Williams TF, Mayewski R. Fall risk index for elderly patients based on number of chronic disabilities. American Journal of Medicine 80: 429–434, 1986
Tinker G. Accidents in the geriatric department. Age and Ageing 18: 196–198, 1977
Thompson TL, Moran MG, Nies AS. Psychotropic drug use in the elderly (first of two parts). New England Journal of Medicine 308: 134–138, 1983
Tyrer P. Risks of dependence on benzodiazepine drugs: the importance of patient selection. British Medical Journal 298: 102–105, 1989
Uhlenhuth EH, de Witt H, Balter MB, Johanson CE, Mellinger GD. Risks and benefits of long-term benzodiazepine use. Journal of Clinical Psychopharmacology 8: 161–167, 1988
Veith RC. Treatment of psychiatric disorders. In Vestal (Ed.) Drug treatment in the elderly, pp. 317–337, ADIS Health Science Press, Sydney, 1984
Vestal RE. Pharmacology and ageing. Journal of the American Geriatrics Society 30: 191–200, 1982
Vestal RE, Jue SG, Cusack BJ. Increased risk of adverse drug reactions in the elderly: fact or myth? In O’Malley & Waddington (Eds) Therapeutics in the elderly: scientific foundations and clinical practice, pp. 97–104, Excerpta Medica, Amsterdam, 1985
Walker K. Repeat prescription recording in general practice. Journal of the Royal College of General Practitioners 21: 748–751, 1971
Weintraub BM. A different view of patient compliance in the elderly. In Vestal (Ed.) Drug treatment in the elderly, pp. 43–50, ADIS Health Science Press, Sydney, 1984
Wells BG, Middleton B, Lawrence G, Lillard D, Safarik J. Factors associated with the elderly falling in intermediate care facilities. Drug Intelligence and Clinical Pharmacy 19: 142–145, 1985
Whitcup SM, Miller F. Unrecognized drug dependence in psychiatrically hospitalized elderly patients. Journal of the American Geriatrics Society 35: 297–301, 1987
Wild D, Nayak USL, Isaacs B. How dangerous are falls in old people at home? British Medical Journal 282: 266–268, 1981
Wilkinson GR. The effects of ageing on the disposition of benzodiazepines in man. In Crooks & Stevenson (Eds) Drugs and the elderly: perspectives in geriatric clinical pharmacology, pp. 103–116, Macmillan Press, London, 1979
Williams P. Factors influencing the duration of treatment with psychotropic drugs in general practice: a survival analysis approach. Psychological Medicine 13: 623–633, 1983
Williamson J, Chopin JM. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age and Ageing 9: 73–80, 1980
World Health Organization, Regional Office for Europe, Copenhagen. Drugs for the elderly, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kruse, W.H.H. Problems and Pitfalls in the Use of Benzodiazepines in the Elderly. Drug-Safety 5, 328–344 (1990). https://doi.org/10.2165/00002018-199005050-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199005050-00003